Evidence map›Paper›PMID 41624896›Full record

ReviewFrontiers in immunology2025

EGPA presenting as sudden cardiac arrest: a case report and review of cardiac manifestations.

Huihui Zhang, Miaolin Zhang, Tao Yu, Zhi Zhang, Mengyang Cai, Gang Wang, Weizong Zhang, Huamin Yu, Hong Yuan

Abstract readCase ReportsReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huihui ZhangDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Miaolin ZhangDepartment of Orthopedics, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Tao YuDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Zhi ZhangSchool of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Mengyang CaiDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Gang WangDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Weizong ZhangDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Huamin YuDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.
Hong YuanDepartment of Cardiovascular Medicine, First People's Hospital of Linping District, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis in which cardiac involvement is a primary cause of mortality. Complete heart block presenting as Adams-Stokes syndrome is a rare but critical complication. Notably, to our knowledge, EGPA initially manifesting as Adams-Stokes syndrome has not been previously documented, based on a comprehensive review of the literature. We report a 27-year-old female presenting with recurrent syncope and seizures. Laboratory tests revealed significant eosinophilia (49.5%), and cardiac workup confirmed third-degree atrioventricular block. A diagnosis of EGPA was established based on the 2022 ACR/EULAR criteria (score=13). Emergency treatment involved temporary pacing and methylprednisolone pulse therapy, followed by mepolizumab induction. Sinus rhythm recovered within 24 hours. During a two-month follow-up, the patient maintained remission with normalized eosinophil counts and improved cardiac function. This case highlights the importance of including EGPA in the differential diagnosis of unexplained high-grade heart block and supports the efficacy of early immunosuppressive therapy in reversing life-threatening cardiac complications.

Indexed as

Death, Sudden, CardiacGranulomatosis with PolyangiitisAdultAntibodies, Monoclonal, HumanizedAtrioventricular BlockDiagnosis, DifferentialFemaleHumansTreatment OutcomeAntibodies, Monoclonal, HumanizedmepolizumabAdams-Stokes syndromeeosinophilic granulomatosis with polyangiitiseosinophilsmepolizumabthird-degree atrioventricular block

Identifiers

PMID41624896
PMCPMC12852314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.